Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ECOR NYSE:NSPR NASDAQ:NTRB NASDAQ:SURG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeECORelectroCore$6.04-1.5%$6.38$4.16▼$8.64$50.08M0.6867,995 shs37,671 shsNSPRInspireMD$1.04+3.5%$1.40$0.97▼$2.93$48.48M0.82182,053 shs131,484 shsNTRBNutriband$3.53$3.83$3.40▼$11.68$42.91M1.9612,216 shs8,517 shsSURGSurgePays$0.51+1.8%$0.69$0.46▼$3.45$12.94M0.32335,641 shs40,141 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceECORelectroCore+3.72%-3.01%-2.85%-0.65%+15.44%NSPRInspireMD0.00%-14.53%-25.93%-42.53%-54.34%NTRBNutriband+0.37%+0.86%-17.70%-15.95%-36.85%SURGSurgePays-4.76%-16.40%-31.49%-38.58%-84.27%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeECORelectroCore$6.04-1.5%$6.38$4.16▼$8.64$50.08M0.6867,995 shs37,671 shsNSPRInspireMD$1.04+3.5%$1.40$0.97▼$2.93$48.48M0.82182,053 shs131,484 shsNTRBNutriband$3.53$3.83$3.40▼$11.68$42.91M1.9612,216 shs8,517 shsSURGSurgePays$0.51+1.8%$0.69$0.46▼$3.45$12.94M0.32335,641 shs40,141 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceECORelectroCore+3.72%-3.01%-2.85%-0.65%+15.44%NSPRInspireMD0.00%-14.53%-25.93%-42.53%-54.34%NTRBNutriband+0.37%+0.86%-17.70%-15.95%-36.85%SURGSurgePays-4.76%-16.40%-31.49%-38.58%-84.27%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceECORelectroCore 2.00Hold$18.00198.26% UpsideNSPRInspireMD 3.00Buy$4.50334.78% UpsideNTRBNutriband 1.50ReduceN/AN/ASURGSurgePays 1.67Reduce$5.00882.32% UpsideCurrent Analyst Ratings BreakdownLatest SURG, ECOR, NSPR, and NTRB Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/15/2026SURGSurgePays Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell5/8/2026NTRBNutriband Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)5/5/2026NSPRInspireMD Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$4.00 ➝ $3.005/4/2026NSPRInspireMD Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$4.004/17/2026SURGSurgePays Ascendiant Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$9.75 ➝ $5.003/27/2026ECORelectroCore Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)3/27/2026ECORelectroCore Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold2/24/2026NSPRInspireMD Loop CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$5.002/24/2026NSPRInspireMD Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy2/23/2026SURGSurgePays Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold(Data available from 5/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookECORelectroCore$32.03M1.56N/AN/A($0.69) per share-8.75NSPRInspireMD$10.85M4.47N/AN/A$1.83 per share0.57NTRBNutriband$2.04M21.07N/AN/A$0.55 per share6.42SURGSurgePays$56.96M0.22N/AN/A($0.66) per share-0.77Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateECORelectroCore-$13.97M-$1.77N/AN/AN/A-44.08%-1,956.38%-83.30%8/5/2026 (Estimated)NSPRInspireMD-$19.92M-$0.73N/AN/AN/A-413.96%-69.42%-57.68%N/ANTRBNutriband-$8.23M-$2.60N/AN/AN/A-403.98%-118.33%-101.92%5/29/2026 (Estimated)SURGSurgePays-$36.07M-$1.94N/A8.48N/A-64.91%-967.32%-290.44%N/ALatest SURG, ECOR, NSPR, and NTRB EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/20/2026Q4 2025SURGSurgePays-$0.19-$0.51-$0.32-$0.51$15.50 million$15.98 million5/6/2026Q1 2026ECORelectroCore-$0.59-$0.59N/A-$0.59$9.01 million$9.58 million3/19/2026Q4 2025ECORelectroCore-$0.35-$0.34+$0.01-$0.34$9.09 million$9.24 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthECORelectroCoreN/AN/AN/AN/AN/ANSPRInspireMDN/AN/AN/AN/AN/ANTRBNutribandN/AN/AN/AN/AN/ASURGSurgePaysN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioECORelectroCoreN/A1.020.86NSPRInspireMDN/A6.396.05NTRBNutriband0.016.366.21SURGSurgePaysN/A0.380.37Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipECORelectroCore26.74%NSPRInspireMD44.78%NTRBNutriband19.70%SURGSurgePays6.94%Insider OwnershipCompanyInsider OwnershipECORelectroCore13.80%NSPRInspireMD34.06%NTRBNutriband52.21%SURGSurgePays29.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableECORelectroCore508.30 million7.15 millionNot OptionableNSPRInspireMD5046.84 million18.33 millionOptionableNTRBNutriband1012.16 million5.81 millionNot OptionableSURGSurgePays4025.12 million17.81 millionOptionableSURG, ECOR, NSPR, and NTRB HeadlinesRecent News About These CompaniesSurgepays Inc (SURG) Q1 2026 Earnings Call Highlights: Robust Revenue Growth Amid Operational ...May 15, 2026 | finance.yahoo.comSurgePays Delays Quarterly Report Filing BrieflyMay 15, 2026 | tipranks.comSurgePays Reports First Quarter 2026 Revenue of Approximately $16 Million, Up 51% Year-Over-Year Driven by Point of Sale and Prepaid Services Growth of 71%May 15, 2026 | globenewswire.comSurgePays, Inc. Launches 25,000 Activation Pilot to Monetize Subprime Customer Base Through Alpha Cash IntegrationMay 12, 2026 | quiverquant.comQSurgePays Launches Alpha Cash Pilot to Monetize Subprime Consumer Distribution, First in a Planned SeriesMay 12, 2026 | globenewswire.comSurgePays to Host First Quarter 2026 Financial Results Conference Call on May 15thMay 11, 2026 | globenewswire.comSurgePays (SURG) Projected to Post Earnings on TuesdayMay 10, 2026 | americanbankingnews.comHow The SurgePays (SURG) Story Is Shifting As Analysts Rework Valuation AssumptionsMay 3, 2026 | finance.yahoo.comF5 Networks (FFIV) Beats Q2 Earnings and Revenue EstimatesApril 28, 2026 | zacks.comSurgePays Advances AI Decisioning Platform Focused on Increasing Revenue Per User Across the Subprime MarketApril 21, 2026 | globenewswire.comSurgePays, Inc. Q4 2025 Earnings Call SummaryApril 16, 2026 | finance.yahoo.comSurgePays, Inc. (NASDAQ:SURG) Q4 2025 Earnings Call TranscriptApril 16, 2026 | insidermonkey.comSurgePays (SURG) Q4 2025 Earnings Call TranscriptApril 15, 2026 | fool.comSurgePays, Inc.: SurgePays Reports Full Year 2025 Results and Highlights Scalable Growth Model with Improved Cost Structure Entering 2026April 15, 2026 | finanznachrichten.deSurgepays Inc (SURG) Q4 2025 Earnings Call Highlights: Navigating Challenges and Capitalizing ...April 15, 2026 | finance.yahoo.comSurgePays (SURG) stock falls 30% overnight: What's going on?April 15, 2026 | msn.comSurgePays, Inc. (SURG) Q4 2025 Earnings Call TranscriptApril 14, 2026 | seekingalpha.comSurgePays Reports Full Year 2025 Results and Highlights Scalable Growth Model with Improved Cost Structure Entering 2026April 14, 2026 | globenewswire.comSurgePays Delays Filing of Annual 10-K ReportApril 10, 2026 | theglobeandmail.comSurgePays Launches Stored Value and Loyalty Platform Across Retail NetworkApril 2, 2026 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesAlphabet’s Earnings Didn’t Just Beat—They Changed the StoryBy Ryan Hasson | April 30, 20265 Stocks to Buy in May Before the Next AI Surge HitsBy Thomas Hughes | May 1, 2026Verizon’s Signal Strength: The Turnaround Call Is Loud and ClearBy Jeffrey Neal Johnson | April 30, 2026Why Smart Money Is Quietly Piling Into This Lithium StockBy Jeffrey Neal Johnson | April 29, 2026Rocket Lab Just Hit a New All-Time High—Time to Buy or Let It Breathe?By Ryan Hasson | May 12, 2026SURG, ECOR, NSPR, and NTRB Company DescriptionselectroCore NASDAQ:ECOR$6.04 -0.10 (-1.55%) As of 03:19 PM Eastern This is a fair market value price provided by Massive. Learn more.electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.InspireMD NYSE:NSPR$1.03 +0.04 (+3.50%) As of 03:18 PM Eastern This is a fair market value price provided by Massive. Learn more.InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.Nutriband NASDAQ:NTRB$3.53 0.00 (0.00%) As of 03:16 PM Eastern This is a fair market value price provided by Massive. Learn more.Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.SurgePays NASDAQ:SURG$0.51 +0.01 (+1.78%) As of 03:21 PM Eastern This is a fair market value price provided by Massive. Learn more.SurgePays, Inc., together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities. SurgePays, Inc. is headquartered in Bartlett, Tennessee. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending Target Shows Strengths, But Analysts Want to See More Freight Boom: The Hormuz Blockade Payday TJX Companies Fires on All Cylinders With 9% Revenue Growth Analog Devices Provides Much-Needed Pullback: How Low Can It Go? USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms From Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 Outlook Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
